NCI Buys Nanogen s NanoChip System | GenomeWeb

NEW YORK, Sept 21 – The US National Cancer Institute (NCI) has purchased Nanogen’s (Nasdaq: NGEN) NanoChip system for use in cancer research and diagnosis, Nanogen said Thursday.

“The NanoChip system may accelerate this process, allowing us to potentially use this same tool in both the research process and in the patient care process,” Stephen Chanock of the NCI’s Pediatric Oncology Branch at the Advanced Technology Center said in a statement.

Terms of the deal were not disclosed. Representatives of NCI and Nanogen could not immediately be reached for comment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.